ALX Oncology Holdings Inc. (ALXO)
NASDAQ: ALXO · Real-Time Price · USD
1.620
+0.140 (9.46%)
Dec 20, 2024, 4:00 PM EST - Market closed
ALX Oncology Holdings Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 |
| Cash & Equivalents | 16.1 | 22.41 | 48.82 | 363.67 | 434.22 | 9.02 | Upgrade
|
| Short-Term Investments | 132.47 | 160.33 | 217.39 | - | - | - | Upgrade
|
| Cash & Short-Term Investments | 148.57 | 182.74 | 266.21 | 363.67 | 434.22 | 9.02 | Upgrade
|
| Cash Growth | -21.81% | -31.36% | -26.80% | -16.25% | 4715.56% | 9.14% | Upgrade
|
| Other Receivables | 1.2 | - | - | - | - | 0.54 | Upgrade
|
| Receivables | 1.2 | - | - | - | - | 0.54 | Upgrade
|
| Prepaid Expenses | 6.12 | 5.92 | 4.76 | 3.35 | 1.77 | 0.26 | Upgrade
|
| Total Current Assets | 155.9 | 188.66 | 270.97 | 367.02 | 435.99 | 9.81 | Upgrade
|
| Property, Plant & Equipment | 10.31 | 10.84 | 9.81 | 3.47 | 0.05 | 0.86 | Upgrade
|
| Long-Term Investments | 14.04 | 35.41 | 16.7 | - | - | - | Upgrade
|
| Other Long-Term Assets | 5.47 | 7.64 | 9.01 | 9.69 | 0.01 | 0.01 | Upgrade
|
| Total Assets | 185.72 | 242.55 | 306.49 | 380.18 | 436.05 | 10.68 | Upgrade
|
| Accounts Payable | 7.89 | 8.59 | 8.07 | 3.76 | 0 | 3.75 | Upgrade
|
| Accrued Expenses | 14.85 | 15.44 | 10.79 | 9.6 | 3.68 | 1.05 | Upgrade
|
| Current Portion of Leases | 1.87 | 1.58 | - | 0.74 | - | - | Upgrade
|
| Current Income Taxes Payable | - | - | - | - | 0.18 | 0 | Upgrade
|
| Other Current Liabilities | 7.73 | 10.4 | 9.46 | 1.19 | 2.35 | 0.19 | Upgrade
|
| Total Current Liabilities | 32.34 | 36 | 28.33 | 15.3 | 6.2 | 4.98 | Upgrade
|
| Long-Term Debt | 9.84 | 9.64 | 9.39 | - | - | 5.42 | Upgrade
|
| Long-Term Leases | 5.66 | 5.98 | - | - | - | - | Upgrade
|
| Other Long-Term Liabilities | 1.08 | 1.22 | 5.31 | 1.84 | 0.01 | 0.55 | Upgrade
|
| Total Liabilities | 48.91 | 52.84 | 43.03 | 17.13 | 6.21 | 10.95 | Upgrade
|
| Common Stock | 0.05 | 0.05 | 0.04 | 0.04 | 0.04 | 0 | Upgrade
|
| Additional Paid-In Capital | 728.15 | 675.68 | 589.74 | 564.99 | 548.33 | 2.14 | Upgrade
|
| Retained Earnings | -591.96 | -486.27 | -325.47 | -201.99 | -118.52 | -72.78 | Upgrade
|
| Comprehensive Income & Other | 0.56 | 0.26 | -0.85 | - | - | - | Upgrade
|
| Total Common Equity | 136.81 | 189.71 | 263.46 | 363.05 | 429.85 | -70.64 | Upgrade
|
| Shareholders' Equity | 136.81 | 189.71 | 263.46 | 363.05 | 429.85 | -0.28 | Upgrade
|
| Total Liabilities & Equity | 185.72 | 242.55 | 306.49 | 380.18 | 436.05 | 10.68 | Upgrade
|
| Total Debt | 17.36 | 17.2 | 9.39 | 0.74 | - | 5.42 | Upgrade
|
| Net Cash (Debt) | 131.22 | 165.54 | 256.82 | 362.93 | 434.22 | 3.6 | Upgrade
|
| Net Cash Growth | -25.01% | -35.54% | -29.24% | -16.42% | 11975.06% | -56.48% | Upgrade
|
| Net Cash Per Share | 2.58 | 3.85 | 6.31 | 9.00 | 23.49 | 1.17 | Upgrade
|
| Filing Date Shares Outstanding | 52.74 | 50.15 | 40.86 | 40.63 | 40.13 | 35.21 | Upgrade
|
| Total Common Shares Outstanding | 52.74 | 49.95 | 40.86 | 40.59 | 39.84 | 3.17 | Upgrade
|
| Working Capital | 123.56 | 152.66 | 242.64 | 351.72 | 429.79 | 4.83 | Upgrade
|
| Book Value Per Share | 2.59 | 3.80 | 6.45 | 8.94 | 10.79 | -22.31 | Upgrade
|
| Tangible Book Value | 136.81 | 189.71 | 263.46 | 363.05 | 429.85 | -70.64 | Upgrade
|
| Tangible Book Value Per Share | 2.59 | 3.80 | 6.45 | 8.94 | 10.79 | -22.31 | Upgrade
|
| Machinery | 2.49 | 2.31 | 1.93 | 0.73 | 0.07 | 1.88 | Upgrade
|
| Leasehold Improvements | 2.51 | 2.51 | 2.36 | 0.23 | 0.01 | 0.43 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.